Abstract
We describe demographic, clinical and programming characteristics of a geographically diverse population implanted with an IPG, with a focus of patients enrolled from Middle East (ME). Data were obtained from PANORAMA, a long term, prospective observational study of 8522 patients from 34 countries implanted with a cardiac rhythm management device between 2005 and 2011. This analysis is based on the 5580 (65%) that were implanted with an IPG, of which 782 patients were enrolled from the ME (Kuwait n = 361 and Saudi Arabia n = 421). Compared to the other regions patients from the ME were more likely to present with diabetes (20% vs 37%, p < 0.001) and less likely to have NYHA class II, III or IV (34% vs 7%, p < 0.001) or atrial fibrillation (33% vs 17%, p < 0.001). The ME region had the highest proportion of patients implanted with a single chamber device and AV block indication. The Panorama IPG cohort provides a unique opportunity to examine the implant practices and clinical profiles of patients implanted with an IPG in the Middle East region. We found significant differences in patient characteristics, type of IPG, and choice of programming. Further work is needed to understand how these differences might contribute to differences in patient management and outcomes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call